Faeth CFO buys 13,634 shares in open market
Faeth Therapeutics, Inc. Chief Financial Officer Brian C. Stephenson, through the Brian Stephenson Revocable Trust, reported open-market purchases of a total of 13,634 shares of common stock over three days.
Rhea-AI Filing Summary
Faeth Therapeutics, Inc. Chief Financial Officer Brian C. Stephenson, through the Brian Stephenson Revocable Trust, reported open-market purchases of a total of 13,634 shares of common stock over three days. On June 29 and 30, 2026, and July 1, 2026, the trust bought multiple blocks of shares at weighted average prices disclosed in the filing, including 4,400 shares at $23.40 and 4,255 shares at $24.98. Following the latest transaction, the trust holds 46,688 shares of Faeth Therapeutics common stock. The footnotes state that Stephenson is the sole trustee of the revocable trust, with sole voting and investment power, while disclaiming beneficial ownership beyond his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 13,634 shares
Net Buy
6 txns
Insider
STEPHENSON BRIAN C
Role
Chief Financial Officer
Bought
13,634 shs ($326K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 4,400 | $23.40 | $103K |
| Purchase | Common Stock | 600 | $24.22 | $15K |
| Purchase | Common Stock | 1,910 | $22.95 | $44K |
| Purchase | Common Stock | 1,638 | $23.88 | $39K |
| Purchase | Common Stock | 4,255 | $24.98 | $106K |
| Purchase | Common Stock | 831 | $23.34 | $19K |
Holdings After Transaction:
Common Stock — 46,688 shares (Indirect, See footnote)
Footnotes (7)
- F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.20 to $23.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F2. These shares are held directly by the Brian Stephenson Revocable Trust (the "Trust"), of which the Reporting Person is the sole trustee and has sole voting and investment power over all securities owned by the Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- F3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.45 to $23.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.50 to $24.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F5. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.59 to $25.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F6. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.14 to $23.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F7. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.14 to $24.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Key Figures
Total shares purchased: 13,634 shares
Post-transaction holdings: 46,688 shares
Largest single trade: 4,400 shares
+3 more
6 metrics
Total shares purchased
13,634 shares
Net open-market purchases reported in this Form 4
Post-transaction holdings
46,688 shares
Common stock held by Brian Stephenson Revocable Trust after July 1, 2026 trade
Largest single trade
4,400 shares
Open-market purchase on July 1, 2026 at $23.40 per share
Price example
$24.98 per share
Weighted average price for 4,255-share purchase on June 30, 2026
Additional trade size
1,910 shares
Open-market purchase on June 30, 2026 at $22.95 per share
Smaller trade size
831 shares
Open-market purchase on June 29, 2026 at $23.34 per share
Key Terms
weighted average price, Revocable Trust, beneficial ownership, pecuniary interest, +1 more
5 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Revocable Trust financial
"These shares are held directly by the Brian Stephenson Revocable Trust (the "Trust")."
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein."
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
FAQ
What insider buying did Faeth Therapeutics (FTH) disclose in this Form 4?
Faeth Therapeutics reported that its CFO, via the Brian Stephenson Revocable Trust, bought a total of 13,634 common shares in open-market transactions. These purchases occurred over three days and increased the trust’s indirect holdings in the company.
Were the Faeth Therapeutics (FTH) transactions open-market purchases or another type?
Each reported transaction is coded as “P” for an open-market or private purchase of common stock. The normalized data describes them as open-market purchases, indicating routine buying activity rather than option exercises or gifts.
AI-generated analysis. How Rhea-AI works. Not financial advice.
